The societal impact of treatment with natalizumab of relapsing–remitting multiple sclerosis in Italian clinical practice: The Tysabri®PharmacoEconomics (TyPE) Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The societal impact of treatment with natalizumab of relapsing–remitting multiple sclerosis in Italian clinical practice: The Tysabri®PharmacoEconomics (TyPE) Study

Published:2019-01 Issue: Volume:2019 Page:228424031985295
ISSN:2284-2403
Container-title:Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish
language:en
Short-container-title:Global & Regional Health Technology Assessment

Author:

Polistena B¹^ORCID,Spandonaro F¹,Capra R²,Fantaccini S³,Santoni L³,Zimatore GB⁴,Gasperini C⁵

Affiliation:

1. C.R.E.A. Sanità, University of Rome Tor Vergata, Rome, Italy

2. Multiple Sclerosis Center, Spedali Civili of Brescia, Brescia, Italy

3. Biogen Italia S.R.L., Milan, Italy

4. U.O. Neurology, P.O. Dimiccoli, Barletta, Italy

5. Department of Neurosciences, San Camillo-Forlanini Hospital, Rome, Italy

Publisher

Aboutscience Srl

Subject

Health Policy

Link

http://journals.sagepub.com/doi/pdf/10.1177/2284240319852956

Reference31 articles.

1. Revised diagnostic criteria of multiple sclerosis

2. Multiple sclerosis: Geoepidemiology, genetics and the environment

3. Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS

4. Social consequences of multiple sclerosis (1): early pension and temporary unemployment—a historical prospective cohort study

5. Life issues in multiple sclerosis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP